XML 28 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Significant and Critical Accounting Policies and Practices (Tables)
9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Schedule of Inventories

Inventory was comprised of the following:

 

    September 30, 2018     December 31, 2017  
Finished goods   $     -     $ 1,204  

Schedule of Estimated Useful Life

Depreciation is computed by the straight-line method (after taking into account their respective estimated residual values) over the estimated useful lives of the respective assets as follows:

 

    Estimated Useful
Life (Years)
 
       
Computer equipment     3  
         
Equipment     2-5  
         
Furniture and fixture     7  
         
Leasehold improvements     *  

 

(*) Amortized on a straight-line basis over the term of the lease or the estimated useful lives, whichever period is shorter.

Schedule of Contingent Share Issuance Arrangements, Stock Options and Warrants

The following table shows the outstanding dilutive common shares excluded from the diluted net income (loss) per share calculation as they were anti-dilutive:

 

    Contingent shares issuance
arrangement, stock options
or warrants
 
    For the Nine
Months
Ended
September 30, 2018
    For the Nine
Months
Ended
September 30, 2017
 
             
Convertible note     16,666,667       16,666,667  
Common stock options     3,743,000       4,643,000  
Common stock warrants     16,666,667       16,666,667  
                 
Total contingent shares issuance arrangement, stock options or warrants     37,076,334       37,976,334  

Schedule of Revisions and Corresponding Effects On Consolidated Statement of Operations

Tabular summaries of the revisions and the corresponding effects on the statement of earnings for the three and nine months ended September 30, 2017 are presented below:

 

   

Consolidated Statement of Operations

Three Months Ended September 30, 2017

 
    Previously Reported     Revisions     Revised Reported  
Change in fair value of derivative liabilities   $ (2,306,470 )   $ 2,306,470     $ -  
                         
Net loss   $ (3,695,439 )   $ 2,306,470     $ (1,388,969 )
                         
Net loss per common share:                        
Basic   $ (0.05 )   $ 0.03     $ (0.02 )
Diluted   $ (0.05 )   $ 0.03     $ (0.02 )

 

Tabular summaries of the revisions and the corresponding effects on the statement of earnings for the nine months ended September 30, 2017 are presented below:

 

   

Consolidated Statement of Operations

Nine Months Ended September 30, 2017

 
    Previously Reported     Revisions    

Revised

Reported

 
Change in fair value of derivative liabilities   $ (661,098 )   $ 661,098     $ -  
                         
Net loss   $ (5,404,839 )   $ 661,098     $ (4,744,384 )
                         
Net loss per common share:                        
Basic   $ (0.08 )   $ 0.01     $ (0.07 )
Diluted   $ (0.08 )   $ 0.01     $ (0.07 )